  Recent studies suggested that excessive Th1/17 cells concomitant with regulatory T cell deficiency might play important roles in Crohn 's disease. Anti-CD52 mAb , which aims on CD52 antigen on mature immunocytes , has both T cell depletion and immunosuppressive activities. In this study , we evaluated the therapeutic effects and possible mechanisms of anti-CD52 treatment on interleukin-10 deficient mouse. Anti-mouse CD52 mAb was administered to C3H.IL-10